These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10660511)

  • 1. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis.
    Darley ES; Bowker KE; Lovering AM; Harvey JE; Macgowan AP
    J Antimicrob Chemother; 2000 Feb; 45(2):247-50. PubMed ID: 10660511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
    Watanuki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of meropenem in the pediatric field].
    Mikuni K; Matsuda H; Watanabe N
    Jpn J Antibiot; 1992 Jun; 45(6):738-43. PubMed ID: 1507405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dosing designs of carbapenems for severe respiratory infection using Monte Carlo simulation.
    Watanabe A; Fujimura S; Kikuchi T; Gomi K; Fuse K; Nukiwa T
    J Infect Chemother; 2007 Oct; 13(5):332-40. PubMed ID: 17982723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic and clinical studies with meropenem in the pediatric field. Pediatric Study Group of Meropenem].
    Fujii R; Yoshioka H; Fujita K; Maruyama S; Sakata H; Inyaku F; Chiba S; Tsutsumi H; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1992 Jun; 45(6):697-717. PubMed ID: 1507401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
    Miyazaki S; Fujikawa T; Kanazawa K; Yamaguchi K
    J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of injectable carbapenems for respiratory infections caused by Streptococcus pneumoniae and Haemophilus influenzae with Monte Carlo simulation].
    Mikamo H; Tanaka K; Watanabe K
    Jpn J Antibiot; 2007 Feb; 60(1):47-57. PubMed ID: 17436862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections of the lower respiratory tract: treatment with amoxicillin.
    Burns MW; Devitt L
    J Infect Dis; 1974 Jun; 129(0):suppl:S194-7. PubMed ID: 4152135
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
    Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of meropenem in experimental meningitis.
    Nairn K; Shepherd GL; Edwards JR
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():73-84. PubMed ID: 8543501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiologic follow-up study in adult bronchiectasis.
    King PT; Holdsworth SR; Freezer NJ; Villanueva E; Holmes PW
    Respir Med; 2007 Aug; 101(8):1633-8. PubMed ID: 17467966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.
    Angrill J; Agustí C; de Celis R; Rañó A; Gonzalez J; Solé T; Xaubet A; Rodriguez-Roisin R; Torres A
    Thorax; 2002 Jan; 57(1):15-9. PubMed ID: 11809984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S; Punyo J
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1337-9. PubMed ID: 15793108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meropenem Dosing Based on a Population Pharmacokinetic-Pharmacodynamic Model in Elderly Patients with Infection of the Lower Respiratory Tract.
    Zhou QT; He B; Shen N; Liang Y; Sun LN
    Drugs Aging; 2017 Feb; 34(2):115-121. PubMed ID: 28097633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic activity of meropenem in experimental infections.
    Edwards JR; Williams S; Nairn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():279-85. PubMed ID: 2681126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.